Iodide

Iodide

SCHEMBL2456403

CC[N+]1(C)CCCCC1.[I-]

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 known ✓ P11229 1/20 0.32
CHRM3 known ✓ P20309 1/20 0.32
KDM4E B2RXH2 1/20 0.48
TP53 P04637 1/20 0.41
CTDSP1 Q9GZU7 2/20 0.39
TSHR P16473 1/20 0.39
CHRNB2 P17787 1/20 0.39
CHRNA4 P43681 1/20 0.39
APOBEC3A P31941 3/20 0.36
APOBEC3G Q9HC16 3/20 0.36
PABPC1 P11940 2/20 0.36
HTT P42858 1/20 0.36
EIF4H Q15056 1/20 0.36
KMT2A Q03164 3/20 0.36
CHRNA7 P36544 3/20 0.35
LMNA P02545 2/20 0.35
BBOX1 O75936 2/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2866854 0.97 KDM4E (0.44) KDM4ETP53CTDSP1TSHRCHRNB2
SCHEMBL372419 0.97
SCHEMBL7607070 0.97 KDM4E (0.44) KDM4ETP53CTDSP1TSHRCHRNB2
Iodide SCHEMBL1681443 0.97
Bromide SCHEMBL9328011 0.94 TP53 (0.46) KDM4ETP53CTDSP1TSHRCHRNB2
Water SCHEMBL4080458 0.94 KDM4E (0.42) KDM4ETP53CTDSP1TSHRCHRNB2
SCHEMBL10851035 0.94 KDM4E (0.42) KDM4ETP53CTDSP1TSHRCHRNB2
Fluoride Ion SCHEMBL30330915 0.94 KDM4E (0.42) KDM4ETP53CTDSP1TSHRCHRNB2
Hydrochloric Acid SCHEMBL9198276 0.94 KDM4E (0.42) KDM4ETP53CTDSP1TSHRCHRNB2
SCHEMBL142703 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5668227-A Cyclohexyl-group-containing glycidyl ethers CIBA-GEIGY CORPORATION (US) 1997-09-16 US claimed
EP-0391370-B1 Epoxy resins CIBA GEIGY AG (CH) 1996-07-03 EP claimed
EP-0555181-A1 Storage-stable advanced epoxy resins CIBA-GEIGY AG (CH) 1993-08-11 EP claimed
US-5019639-A Chain extension with aliphatic diol and phenolic diol, coatings, lamination, pregregs, low viscosity CIBA-GEIGY CORPORATION (US) 1991-05-28 US claimed
EP-0391370-A2 Epoxy resins CIBA-GEIGY AG (CH) 1990-10-10 EP claimed
WO-2025100238-A1 EPOXY COMPOUND AND USE THEREOF 四国化成工業株式会社 2025-05-15 WO disclosed
WO-2025062839-A1 COMPOUND, EPOXY RESIN, CURABLE COMPOSITION, MATERIAL FOR RECYCLING, CURED ARTICLE, METHOD FOR PRODUCING CURED ARTICLE, METHOD FOR PRODUCING DECOMPOSITION PRODUCT, AND DECOMPOSITION METHOD 株式会社ADEKA 2025-03-27 WO disclosed
CN-113891882-B Process for producing dihydroisoxazole 组合化学工业株式会社 2024-11-26 CN disclosed
US-12065541-B2 Thermoplastic resin, optical film made therefrom, diol compound, diester compound MITSUBISHI CHEMICAL CORPORATION (JP) 2024-08-20 US disclosed
CN-114478336-B Process for producing mercaptophenol compound and intermediate therefor 组合化学工业株式会社 2024-05-14 CN disclosed
US-20240084065-A1 NOVEL COMPOUND, AND CURABLE RESIN COMPOSITION CONTAINING SAID COMPOUND ADEKA CORPORATION (JP) 2024-03-14 US disclosed
EP-4289837-A1 NOVEL COMPOUND, AND CURABLE RESIN COMPOSITION CONTAINING SAID COMPOUND ADEKA CORPORATION (JP) 2023-12-13 EP disclosed
EP-0597806-A1 Novel cyclohexyl substituted glycidylethers CIBA-GEIGY AG (CH) 1994-05-18 EP disclosed
EP-0559607-A2 Epoxy resins based on triglycidyl isocyanurate CIBA-GEIGY AG (CH) 1993-09-08 EP disclosed
EP-0555181-A1 Storage-stable advanced epoxy resins CIBA-GEIGY AG (CH) 1993-08-11 EP disclosed
US-5019639-A Chain extension with aliphatic diol and phenolic diol, coatings, lamination, pregregs, low viscosity CIBA-GEIGY CORPORATION (US) 1991-05-28 US disclosed
EP-0391370-A2 Epoxy resins CIBA-GEIGY AG (CH) 1990-10-10 EP disclosed
US-4885354-A Epoxy resin compositions CIBA-GEIGY CORPORATION (US) 1989-12-05 US disclosed
EP-0314619-A2 Epoxy resin mixture CIBA-GEIGY AG (CH) 1989-05-03 EP disclosed
EP-0073645-A2 2-Cyclic amino-2-(1,2-benzisoxazol-3-yl)acetic acid ester derivatives, process for the preparation thereof and composition containing the same Dainippon Pharmaceutical Co., Ltd. (JP) 1983-03-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12065541-B2 Thermoplastic resin, optical film made therefrom, diol compound, diester compound RTF1, RNF31, RNF10 CHRM1 581/4885CHRM3 2295/4885KDM4E 1758/4885
US-20240084065-A1 NOVEL COMPOUND, AND CURABLE RESIN COMPOSITION CONTAINING SAID COMPOUND PSMC6, CAND1, RBX1 CHRM1 418/4885CHRM3 2075/4885KDM4E 261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.